[#item_full_content] Registration Aligns With The Federal Rescheduling of Cannabis to Schedule III, Which Grants Federal Safe Harbor To Licensed Operators And Removes IRS Section 280E RestrictionsNORWOOD, Mass., June 25, 2026 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator, today announced the Company has submitted applications with the U.S. Drug Enforcement Agency (“DEA”) to register certain state-licensed medical cannabis operations. Read More